Natco Pharma informs about press release

13 Nov 2020 Evaluate

Natco Pharma has informed that it has enclosed the Press Release on 13 November 2020 titled ‘ NATCO receives Pomalidomide approval for US market’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

813.65 -18.10 (-2.18%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×